Literature DB >> 33388990

Prognostic risk factors for initially diagnosed T2N0M0 glottic cancer: competing risk analysis and propensity-score matched cohort analysis.

Guan-Jiang Huang1, Bei-Bei Yang2.   

Abstract

BACKGROUND: Prognostic risk factors of patients with initially diagnosed T2N0M0 glottic cancer remain unclear. This study was aimed to conduct a comprehensive analysis to identify valuable prognostic risk factors for initially diagnosed T2N0M0 glottic cancer.
METHODS: Data of patients with initially diagnosed T2N0M0 glottic cancer were extracted from the Surveillance, Epidemiology, and End Results database. Survival analyses and Cox regression analyses were conducted to evaluate overall survival (OS) and cancer-specific survival (CSS). In consideration of competing events, the competing risk (CR) analysis was applied. Furthermore, propensity-score matching (PSM) was applied to mimic randomized-controlled trials and reduce selection bias.
RESULTS: A total of 923 eligible patients met the inclusion criteria. Survival analyses showed that age, marital status, primary site surgery, and radiation were independent predictors of OS. Besides, age, marital status, primary site surgery, radiation, and chemotherapy were independent predictors of CSS. Cox regression analyses and the CR analysis were basically consistent with this result. In addition, an internal validation and PSM were performed to explore the role of chemotherapy.
CONCLUSION: We conducted a comprehensive analysis to prove that age, marital status, primary site surgery, radiation, and chemotherapy may be valuable prognostic risk factors for initially diagnosed T2N0M0 glottic cancer. Primary site surgery and radiation should be recommended, whereas chemotherapy was likely not suitable so far. Furthermore, we constructed a CR nomogram to predict survival rates.

Entities:  

Keywords:  Adjuvant chemotherapy; Glottis; Laryngeal neoplasms; Laryngoscopy; Radiotherapy; Risk factors; SEER program; Surgery

Year:  2021        PMID: 33388990     DOI: 10.1007/s00405-020-06557-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  4 in total

1.  National Trends in the US Public's Likelihood of Getting a COVID-19 Vaccine-April 1 to December 8, 2020.

Authors:  Peter G Szilagyi; Kyla Thomas; Megha D Shah; Nathalie Vizueta; Yan Cui; Sitaram Vangala; Arie Kapteyn
Journal:  JAMA       Date:  2020-12-29       Impact factor: 56.272

2.  Transoral laser microsurgery for Tis, T1, and T2 glottic carcinoma: 5-year follow-up.

Authors:  D De Seta; Flaminia Campo; V D'Aguanno; M Ralli; A Greco; F Y Russo; M de Vincentiis
Journal:  Lasers Med Sci       Date:  2020-05-29       Impact factor: 3.161

3.  Carbon Dioxide Laser Microsurgery versus Low-Temperature Plasma Radiofrequency Ablation for T1a Glottic Cancer: A Single-Blind Randomized Clinical Trial.

Authors:  Yan Zhang; Binru Wang; Guangbin Sun; Guoliang Zhang; Ling Lu; Gengtian Liang
Journal:  Biomed Res Int       Date:  2018-11-01       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.